TTR and Alzheimer disease: Many studies have suggested that alpha-2-macroglobulin, apolipoproteins, transthyretin, clusterin and the complement system are involved in AD pathogenesis through the sequestration of Aβ, leading to increased Aβ clearance in vivo [64–67].